Published in Lancet on August 30, 2003
Disturbances of electrolytes and blood chemistry in acute alcohol intoxication. Wien Klin Wochenschr (2005) 1.47
A funny patient. J R Soc Med (2007) 1.06
Dietary poisoning with Veratrum album--a report of two cases. Wien Klin Wochenschr (2005) 1.02
Comparison of image quality and radiation dose of different pulmonary CTA protocols on a 128-slice CT: high-pitch dual source CT, dual energy CT and conventional spiral CT. Eur Radiol (2011) 0.93
Long-term survival and neurological outcome of patients who received recombinant tissue plasminogen activator during out-of-hospital cardiac arrest. Resuscitation (2004) 0.84
The smoker's paradox and the real risk of smoking. Eur J Epidemiol (2005) 0.79
Problematic drugs in elderly patients presenting to a European emergency room. Eur J Intern Med (2003) 0.79
Lack of association of soluble CD40 ligand with the presence of acute myocardial infarction or ischemic stroke in the emergency department. Clin Chem (2008) 0.78
Quality of health care delivered to adults in the United States. N Engl J Med (2003) 0.78
Repeated premature hemofilter clotting during regional citrate anticoagulation as indicator of heparin induced thrombocytopenia. Blood Purif (2014) 0.77
Psychiatric disorders and the ICU: gaps and opportunities. Intensive Care Med (2008) 0.77
Emergency correction of coagulation before major surgery in two elderly patients on oral anticoagulation. Thromb J (2007) 0.76
Anticoagulation for atrial fibrillation: underuse? Am J Med (2011) 0.76
The RITA 3 trial. Lancet (2002) 0.75
Enoxaparin vs unfractionated heparin in acute coronary syndrome. JAMA (2004) 0.75
Patient outcome of invasive experiments. Am J Respir Crit Care Med (2004) 0.75
Statins and sepsis. Lancet (2006) 0.75
Coated central venous catheters: mortality, illness severity? Crit Care Med (2011) 0.75
The CHARM programme. Lancet (2003) 0.75
Roflumilast for chronic obstructive pulmonary disease. Lancet (2005) 0.75
Cetuximab plus radiotherapy for head and neck cancer. N Engl J Med (2006) 0.75
Fondaparinux in patients with ST-segment elevation myocardial infarction. JAMA (2006) 0.75
Heparin in sepsis treatment. Lancet (2007) 0.75
Anticoagulant-related bleeding risk in older persons: unfounded fears? Arch Intern Med (2004) 0.75
Antiphospholipid testing and outcome. Arch Intern Med (2004) 0.75
Ranolazine as add-on therapy for patients with severe chronic angina. JAMA (2004) 0.75
NEOPAIN: a question of survival. Lancet (2004) 0.75
Adverse events in diabetes drug trial. Lancet (2009) 0.75
Patients with high-risk acute myocardial infarction randomized to one of two treatment strategies: delay and eligibility questions. J Am Coll Cardiol (2003) 0.75
Antibacterial prophylaxis in patients with cancer and neutropenia. N Engl J Med (2006) 0.75
Thrombolytic therapy vs angioplasty in acute myocardial infarction. JAMA (2002) 0.75
Dabigatran versus enoxaparin after total hip replacement. Lancet (2007) 0.75
Prevention of postoperative nausea and vomiting. N Engl J Med (2004) 0.75
Molecular characterization of three novel splicing mutations causing factor V deficiency and analysis of the F5 gene splicing pattern. Haematologica (2008) 0.75
Sweet heart block. Circulation (2008) 0.75
Antiphospholipid syndrome. What benefit has the label? BMJ (2010) 0.75
A hidden cause of angina pectoris: when ABG analysis is the only helpful diagnostic tool. Int J Cardiol (2005) 0.75